Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne
Public ClinicalTrials.gov record NCT00594425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multicenter study will be divided into 2 phases. The first phase will be an open label, dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled, parallel-group, dose-response phase. The second phase will only start if the first phase succeeds in establishing well tolerated dose(s). Patients with moderate to severe acne vulgaris in the face will be included.The results from part 2 has been presented in the result section.
Study identification
- NCT ID
- NCT00594425
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 15 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2007
- Primary completion
- Jun 30, 2008
- Completion
- Aug 31, 2008
- Last update posted
- Aug 7, 2013
2007 – 2008
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Solano Clinical Research | Vallejo | California | 94589 | — |
| DuPage Medical Group | Naperville | Illinois | 60563 | — |
| Michigan Center for Research Corp | Clinton Twp | Michigan | 48038 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106 | — |
| Dermatology Associates of Rochester | Rochester | New York | 14623 | — |
| Central Sooner Research | Norman | Oklahoma | 73069 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Dermatology Treatment & Research | Dallas | Texas | 75230 | — |
| Suzanne Bruce and Associates, PA | Houston | Texas | 77056 | — |
| The Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
| Dermatology Research Center, Inc. | Salt Lake City | Utah | 84124 | — |
| The Education & Research Foundation, Inc. | Lynchburg | Virginia | 24501-1604 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00594425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2013 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00594425 live on ClinicalTrials.gov.